Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy in Vietnam

Recruiting now · Not applicable

Conditions studied: Hypoxic-ischemic Encephalopathy (HIE)

In brief

This study aims to evaluate the effectiveness of therapeutic hypothermia in neonates diagnosed with hypoxic-ischemic encephalopathy (HIE). The study focuses on assessing both short-term outcomes after treatment and long-term neurological outcomes following therapeutic hypothermia.

Key facts

Study ID

NCT07555652

Run by

National Children's Hospital, Vietnam

People needed

120

Starts

2025-06-10

Expected to finish

2028-02-01

Last updated by the study team

2026-04-29

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Neonates diagnosed with hypoxic-ischemic encephalopathy (HIE) at the Neonatal Center, National Children's Hospital
• Gestational age ≥ 36 weeks
• Assessed using the modified Sarnat staging within the first 0-6 hours after birth
• Eligible for and/or treated with therapeutic hypothermia according to institutional protocol
• Underwent clinical and paraclinical monitoring during hospitalization
• Received brain magnetic resonance imaging (MRI) during the neonatal period (from 5 to 17 days of age)
• Availability of complete medical records for data collection and analysis

You may not qualify if…

• Presence of major congenital anomalies, particularly involving the central nervous system
• Absence of brain MRI during the study period
• Refusal of participation by parent(s) or legal guardian(s)

Where it is running

• Vietnam National Children's Hospitalv — Ha Nội, Hanoi, Vietnam (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.